Mylan NV (NASDAQ:MYL)

69.66
Delayed Data
As of May 22
 -0.28 / -0.40%
Today’s Change
44.80
Today|||52-Week Range
76.69
+23.58%
Year-to-Date

Today’s Trading

Previous close69.94
Today’s open70.00
Day’s range69.49 - 70.55
Volume4,333,753
Average volume (3 months)9,105,707
Market cap$34.1B
Dividend yield--
Data as of 3:59pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+48.10%
Earnings growth (this year)+15.44%
Earnings growth (next 5 years)+10.37%
Revenue growth (last year)+12.42%
P/E ratio30.0
Price/Sales2.71
Price/Book8.03

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...+3.37+2.00%
VRTXVertex Pharmaceutica...+0.03+0.02%
PRGOPerrigo Company PLC+0.21+0.11%
ZTSZoetis Inc-0.17-0.36%
Data as of 4:02pm ET, 05/22/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$0.92
Annual revenue (last year)$7.8B
Annual profit (last year)$929.4M
Net profit margin11.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Potters Bar, Hertfordshire

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers